• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-520f通过靶向TM4SF1抑制肝癌细胞的增殖和侵袭。

microRNA-520f inhibits hepatocellular carcinoma cell proliferation and invasion by targeting TM4SF1.

作者信息

Du Xiaoqin, Fan Wanhu, Chen Yunru

机构信息

Department of Infectious Diseases, Weinan Center Hospital of Shaanxi Province, Weinan 714000, Shaanxi, China.

Department of Infectious Diseases, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi, China.

出版信息

Gene. 2018 May 30;657:30-38. doi: 10.1016/j.gene.2018.03.003. Epub 2018 Mar 2.

DOI:10.1016/j.gene.2018.03.003
PMID:29505836
Abstract

microRNAs (miRNAs) are reported to play crucial roles in tumorigenesis. Dysregulation of miR-520f has been implicated to be involved in several cancer progressions. However, the biological functions of miR520f in hepatocellular carcinoma (HCC) remain unclear. Thus, the molecular mechanism underlying miR-520f on HCC development was investigated in this study. Here, we found that miR-520f was remarkably down-regulated in human HCC samples and cell lines compared to paired normal tissues and cell lines as detected by qRT-PCR. Furthermore, the deregulated miR-520f was strongly associated with larger tumor size, advanced TNM stage, and metastasis in HCC patients. Functional investigations revealed that overexpression of miR-520f significantly suppressed cell proliferation, invasion and migration, caused cell cycle arrested at G0/G1 phase, and promoted cell apoptosis in HCC cells according to MTT, colony formation, transwell, and flow cytometry assays, respectively, whereas, downregulation of miR-520f exhibited inverse effects. Transmembrane-4 L-Six family member-1 (TM4SF1) was identified as a direct target of miR-520f, and an inverse relationship was found between miR-520f and TM4SF1 mRNA levels in HCC specimens. Rescue experiments suggested that restoration of TM4SF1 partially abolished miR-520f-meidated cell proliferation and invasion inhibition in HCC cells through regulating P13K/AKT and p38 MAPK signaling pathways. In conclusion, these data indicated that miR-520f acted as tumor suppressor in HCC proliferation and invasion by targeting TM4SF1, which might provide potential therapeutic evidence for HCC patients.

摘要

据报道,微小RNA(miRNA)在肿瘤发生过程中发挥着关键作用。miR-520f的失调与多种癌症进展有关。然而,miR-520f在肝细胞癌(HCC)中的生物学功能仍不清楚。因此,本研究探讨了miR-520f在HCC发生发展中的分子机制。通过qRT-PCR检测,我们发现与配对的正常组织和细胞系相比,miR-520f在人类HCC样本和细胞系中显著下调。此外,失调的miR-520f与HCC患者更大的肿瘤大小、晚期TNM分期和转移密切相关。功能研究表明,根据MTT、集落形成、transwell和流式细胞术分析,miR-520f的过表达显著抑制了HCC细胞的增殖、侵袭和迁移,使细胞周期停滞在G0/G1期,并促进了细胞凋亡,而miR-520f的下调则表现出相反的效果。跨膜4 L-六家族成员1(TM4SF1)被鉴定为miR-520f的直接靶点,并且在HCC标本中发现miR-520f与TM4SF1 mRNA水平呈负相关。挽救实验表明,通过调节P13K/AKT和p38 MAPK信号通路,TM4SF1的恢复部分消除了miR-520f介导的HCC细胞增殖和侵袭抑制。总之,这些数据表明,miR-520f通过靶向TM4SF1在HCC增殖和侵袭中发挥肿瘤抑制作用,这可能为HCC患者提供潜在的治疗依据。

相似文献

1
microRNA-520f inhibits hepatocellular carcinoma cell proliferation and invasion by targeting TM4SF1.微小RNA-520f通过靶向TM4SF1抑制肝癌细胞的增殖和侵袭。
Gene. 2018 May 30;657:30-38. doi: 10.1016/j.gene.2018.03.003. Epub 2018 Mar 2.
2
MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.微小RNA-655-3p通过调节肝细胞癌中的ADAM10和β-连环蛋白通路发挥肿瘤抑制作用。
J Exp Clin Cancer Res. 2016 Jun 4;35(1):89. doi: 10.1186/s13046-016-0368-1.
3
MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer.微小RNA-9通过下调结直肠癌中的TM4SF1抑制细胞迁移和侵袭。
Int J Oncol. 2016 May;48(5):2135-43. doi: 10.3892/ijo.2016.3430. Epub 2016 Mar 9.
4
MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1.miRNA-206 通过靶向 TM4SF1 抑制 PGE2 诱导的结直肠癌细胞增殖、迁移和侵袭。
Biosci Rep. 2018 Sep 19;38(5). doi: 10.1042/BSR20180664. Print 2018 Oct 31.
5
MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.微小RNA-451:上皮-间质转化抑制剂及肝细胞癌的预后生物标志物
Oncotarget. 2015 Jul 30;6(21):18613-30. doi: 10.18632/oncotarget.4317.
6
MiR-451a suppresses cell proliferation, metastasis and EMT via targeting YWHAZ in hepatocellular carcinoma.微小RNA-451a通过靶向14-3-3ζ抑制肝癌细胞的增殖、转移和上皮-间质转化。
Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5158-5167. doi: 10.26355/eurrev_201906_18180.
7
MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma.微小 RNA-493 通过靶向 ZFX 抑制人肝癌细胞的增殖和侵袭。
Cancer Biomark. 2018;22(3):427-434. doi: 10.3233/CBM-171036.
8
microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3β in hepatocellular carcinoma cells.微小RNA-141通过靶向肝癌细胞中的肝细胞核因子-3β抑制细胞增殖和侵袭并促进细胞凋亡。
BMC Cancer. 2014 Nov 25;14:879. doi: 10.1186/1471-2407-14-879.
9
MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.MicroRNA-504 通过抑制卷曲蛋白 7 介导的 Wnt/β-catenin 信号通路在肝癌中发挥肿瘤抑制作用。
Biomed Pharmacother. 2018 Nov;107:754-762. doi: 10.1016/j.biopha.2018.07.150. Epub 2018 Aug 21.
10
MiR-613 functions as tumor suppressor in hepatocellular carcinoma by targeting YWHAZ.miR-613 通过靶向 YWHAZ 在肝癌中发挥肿瘤抑制作用。
Gene. 2018 Jun 15;659:168-174. doi: 10.1016/j.gene.2018.03.036. Epub 2018 Mar 15.

引用本文的文献

1
Integrated multi-omics analyses reveal the TM4SF family genes with prognostic and therapeutic relevance in hepatocellular carcinoma.整合多组学分析揭示 TM4SF 家族基因在肝细胞癌中具有预后和治疗相关性。
Aging (Albany NY). 2024 Jan 10;16(1):593-616. doi: 10.18632/aging.205398.
2
A systematic review of progress on hepatocellular carcinoma research over the past 30 years: a machine-learning-based bibliometric analysis.过去30年肝细胞癌研究进展的系统综述:基于机器学习的文献计量分析
Front Oncol. 2023 Aug 17;13:1227991. doi: 10.3389/fonc.2023.1227991. eCollection 2023.
3
Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance.
跨膜4超家族的三个成员,即TM4SF1、TM4SF4和TM4SF5,作为针对癌症表型和化疗耐药性的新兴抗癌分子靶点。
Pharmaceuticals (Basel). 2023 Jan 11;16(1):110. doi: 10.3390/ph16010110.
4
Immune-related gene TM4SF18 could promote the metastasis of gastric cancer cells and predict the prognosis of gastric cancer patients.免疫相关基因 TM4SF18 可促进胃癌细胞的转移,并预测胃癌患者的预后。
Mol Oncol. 2022 Dec;16(22):4043-4059. doi: 10.1002/1878-0261.13321. Epub 2022 Oct 20.
5
Differential expression of microRNA between triple negative breast cancer patients of African American and European American descent.非裔美国人和欧洲裔美国人的三阴性乳腺癌患者之间 microRNA 的差异表达。
Biotech Histochem. 2022 Jan;97(1):1-10. doi: 10.1080/10520295.2021.2005147. Epub 2022 Jan 4.
6
Exosome encapsulated ncRNAs in the development of HCC: potential circulatory biomarkers and clinical therapeutic targets.外泌体包裹的非编码RNA在肝癌发生发展中的作用:潜在的循环生物标志物和临床治疗靶点
Am J Cancer Res. 2021 Aug 15;11(8):3794-3812. eCollection 2021.
7
Long Noncoding RNA WEE2-AS1 Plays an Oncogenic Role in Glioblastoma by Functioning as a Molecular Sponge for MicroRNA-520f-3p.长链非编码 RNA WEE2-AS1 通过作为 microRNA-520f-3p 的分子海绵在胶质母细胞瘤中发挥致癌作用。
Oncol Res. 2021 Mar 16;28(6):591-603. doi: 10.3727/096504020X15982623243955. Epub 2020 Aug 24.
8
TM4SF1, a binding protein of DVL2 in hepatocellular carcinoma, positively regulates beta-catenin/TCF signalling.TM4SF1 是肝癌中 DVL2 的结合蛋白,正向调节β-catenin/TCF 信号通路。
J Cell Mol Med. 2021 Mar;25(5):2356-2364. doi: 10.1111/jcmm.14787. Epub 2019 Dec 26.
9
MiR-520f acts as a biomarker for the diagnosis of lung cancer.微小RNA-520f作为肺癌诊断的生物标志物。
Medicine (Baltimore). 2019 Jul;98(30):e16546. doi: 10.1097/MD.0000000000016546.
10
TM4SF18 is aberrantly expressed in pancreatic cancer and regulates cell growth.TM4SF18 在胰腺癌中异常表达,并调节细胞生长。
PLoS One. 2019 Mar 21;14(3):e0211711. doi: 10.1371/journal.pone.0211711. eCollection 2019.